University Health Network
π¨π¦Canada
- Country
- π¨π¦Canada
- Ownership
- Private
- Established
- 1999-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uhn.ca
Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 1
Completed
- Conditions
- Head and Neck Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2018-10-10
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 51
- Registration Number
- NCT00030576
- Locations
- π¨π¦
Ottawa Regional Cancer Centre, Ottawa, Ontario, Canada
π¨π¦Princess Margaret Hospital, Toronto, Ontario, Canada
π¨π¦Queen's University, Kingston, Ontario, Canada
Tipifarnib in Treating Patients With Recurrent Bladder Cancer
Phase 2
Completed
- Conditions
- Bladder Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- University Health Network, Toronto
- Registration Number
- NCT00047216
- Locations
- πΊπΈ
Louis A. Weiss Memorial Hospital, Chicago, Illinois, United States
πΊπΈUniversity of Chicago Cancer Research Center, Chicago, Illinois, United States
π¨π¦St. Joseph's Hospital, Hamilton, Ontario, Canada
Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
Phase 2
Completed
- Conditions
- Liver Cancer
- Interventions
- Biological: oblimersen sodiumDrug: doxorubicin hydrochloride
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-11-08
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 27
- Registration Number
- NCT00047229
- Locations
- π¨π¦
British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
π¨π¦London Regional Cancer Program at London Health Sciences Centre, London, Ontario, Canada
π¨π¦Princess Margaret Hospital, Toronto, Ontario, Canada
Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-07-23
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 9
- Registration Number
- NCT00052494
- Locations
- π¨π¦
Princess Margaret Hospital, Toronto, Ontario, Canada
Angioplasty and Heart Stents to Treat Individuals With an Occluded Artery Following a Heart Attack
Phase 4
Completed
- Conditions
- Coronary DiseaseHeart DiseasesMyocardial InfarctionCardiovascular Diseases
- Interventions
- Behavioral: Optimal Medical TherapyDevice: PCI with stenting
- First Posted Date
- 2001-10-23
- Last Posted Date
- 2013-11-27
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 380
- Registration Number
- NCT00025766
- Locations
- π¨π¦
University Health Network - Toronto General Hospital, Toronto, Ontario, Canada
Β© Copyright 2025. All Rights Reserved by MedPath